Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

BCL6 anticorps (AA 256-389)

Cet anticorps Souris Monoclonal détecte spécifiquement BCL6 dans WB. Il présente une réactivité envers Humain.
N° du produit ABIN6940527

Aperçu rapide pour BCL6 anticorps (AA 256-389) (ABIN6940527)

Antigène

Voir toutes BCL6 Anticorps
BCL6 (B-Cell CLL/lymphoma 6 (BCL6))

Reactivité

  • 159
  • 61
  • 25
  • 9
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Humain

Hôte

  • 92
  • 65
  • 2
  • 1
Souris

Clonalité

  • 98
  • 62
Monoclonal

Conjugué

  • 79
  • 13
  • 7
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 1
Cet anticorp BCL6 est non-conjugé

Application

  • 70
  • 69
  • 40
  • 38
  • 32
  • 26
  • 18
  • 13
  • 11
  • 8
  • 5
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB)

Clone

BCL6-1475
  • Épitope

    • 60
    • 11
    • 11
    • 7
    • 4
    • 4
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 256-389

    Specificité

    The specificity of this monoclonal antibody to its intended target was validated by HuProtTM Array, containing more than 19,000, full-length human proteins. Recognizes a protein of 95 kDa, which is identified as Bcl-6. Antibody to bcl-6 is helpful in a number of diagnostic settings: (1) In the differential diagnosis of small B-cell lymphoma. Follicular lymphoma will show bcl-6 (and CD10) positivity whereas other small B-cell lymphomas are usually negative. (2) Bcl-6 is an important prognostic marker in diffuse large B-cell lymphomas (DLBCL), where CD10, bcl-6 and MUM1/IRF4 are used to identify germinal center and activated B-cell phenotypes. (3) Bcl-6 can be valuable in distinguishing classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma (NLPHL). The Reed-Sternberg cells of classical Hodgkin lymphoma are bcl-6 negative whereas the large ('LH') cells of NLPHL are bcl-6 positive. In contrast, anti-Bcl-6 rarely stains mantle-cell lymphoma and MALT lymphoma.

    Purification

    Purified by Protein A/G

    Immunogène

    Recombinant human bcl-6 protein fragment (around aa256-389) (exact sequence is proprietary)

    Isotype

    IgG1 kappa
  • Indications d'application

    Positive Control: Raji or Ramos cells. Tonsil.

    Known Application: Western Blot (0.5-1 μg/mL)Optimal dilution for a specific application should be determined.

    Restrictions

    For Research Use only
  • Concentration

    200 μg/mL

    Buffer

    10 mM PBS with 0.05 % BSA & 0.05 % azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-80 °C

    Stockage commentaire

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Date de péremption

    24 months
  • Antigène

    BCL6 (B-Cell CLL/lymphoma 6 (BCL6))

    Autre désignation

    BCL6

    Poids moléculaire

    95kDa

    ID gène

    604

    UniProt

    P41182

    Pathways

    Chromatin Binding, Regulation of Leukocyte Mediated Immunity, Production of Molecular Mediator of Immune Response, Protein targeting to Nucleus
Vous êtes ici:
Chat with us!